Geode Capital Management, LLC Tg Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,282,567 shares of TGTX stock, worth $118 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,282,567
Previous 3,193,505
2.79%
Holding current value
$118 Million
Previous $96.1 Million
34.65%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding TGTX
# of Institutions
415Shares Held
87.9MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$561 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$410 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$267 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$102 Million9.29% of portfolio
-
Clearbridge Investments, LLC New York, NY2.64MShares$95.1 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.23B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...